According to Goldstein Research, global imaging biomarker market is expected to grow at considerable CAGR over the forecast period 2017-2025. The factors such as growth in toxicity profiling cases, rising number of hospitals, and targeted drug discovery are driving the growth of the Imaging Biomarker Market. The expansion of the market is simultaneously expanding the application of biomarkers such as in Cancer treatment. The global cancer biomarker market is still at nascent stage and has not yet received approval from FDA, but tremendous R&D will lead to definite results in near future. Further, imaging biomarker has initiated the trend of ‘precision medicine’ wherein tailored treatment is provided to the individual patient. Hence, global biomarker validation and testing market growth structure has huge impact on the growth ®ulatory approval of imaging biomarkers.
Market Segmentation
On the basis of our in-depth analysis, Global Imaging Biomarker Market can be segmented as follows:
By Imaging Technology
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Magnetic Resonance Imaging (MRI)
- Ultrasound (US)
- Single Photon Emission Computed Tomography (SPECT)
By Product Type
- Hormones
- Enzymes
- Antibodies
- Gene products
By Therapeutic Areas
- Oncology
- Cardiology
- Immunology
- Neurology
- Others (Hematology, Biochemistry, etc.)
By Application
- Drug Discovery and Development
- Disease Diagnosis
- Genetic Studies
- Molecular Diagnostics
- Bioinformatics
- Others (Forensic Application, etc.)
By End-User
- Pharmaceutical Companies
- Hospitals
- Research Labs and Institutes
- Contract Research Organizations (CROs)
By Region
- North America Imaging Biomarker Market Analysis, 2017-2025
- Europe Imaging Biomarker Market Analysis, 2017-2025
- Middle East And Africa Imaging Biomarker Market Analysis, 2017-2025
- Latin America Imaging Biomarker Market Analysis, 2017-2025
- Asia Pacific Imaging Biomarker Market Analysis, 2017-2025
“Global Imaging Biomarker Market Outlook 2025” includes a comprehensive overview of the global imaging biomarker market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by imaging technology, product type, therapeutic areas, application, end user and geography.
The Global Imaging Biomarker Market Report highlights the competitive outlook of major global players that includes business strategies, product portfolio, revenue distribution, financial analysis, R&D activities and investments. The comprehensive analysis of imaging biomarker market report is drafted as per the clients to help them in assessing their business strategies in the competitive environment.
Further, Global Imaging Biomarker Market Report encompasses the key factors driving the growth of the market, opportunities in the market and the factors posing threats & challenges to the market. The imaging biomarker market outlook also comprises the market dynamics, risk analysis, SWOT analysis, USP analysis, BPS Analysis & market attractiveness. Report further also includes the expert analysis and remarks showcasing the complete overview of the market based on intensive analysis of political, economic, social, technological, environmental & legal factors of each region in the market.
Global Imaging Biomarker Market is driving on the basis of advancement in branches of healthcare mentioned below:
Computed Tomography Market
global computed tomography market size was valued at USD 183.5 million in 2016, which is anticipated to grow at a CAGR of 5.0% during the forecast period. The factors such as need for preventive health care, technology advancement, increasing incidences of health issues such as cardiovascular diseases and growth in insurance coverage policies are driving the growth of CT market.
Medical Ultrasound Devices Market
Global Medical Ultrasound Devices Market is facing high competition owing to presence of huge players such as Philips Healthcare, Siemens, GE Healthcare and others. Global presence of these healthcare equipment manufacturers is one of the major factors which are creating huge challenge for the new players to enter into the market. Global ultrasound market is expected to generate revenue of USD 7.5 billion by 2024 from USD 5.0 billion in 2016.
Bioinformatics Market
The bioinformatics market is expected to grow at a CAGR of 20.5% over the forecast period 2016-2024 to reach a market size of USD 17.5billion by 2024. Major driving factor for bioinformatics market is the application and development of data mining techniques to solve biological problems as analyzing large biological data sets requires making sense of the data by inferring structure or generalizations from the data.
Metabolomics Market
Major driving factor for global metabolomics market improving the route from early drug discovery through clinical development as drug discovery is risky and complex process with just 12% of drugs entering the clinical trials ever to make it to the patients. the Metabolomics market size is set to reach USD 2.1 billion by 2024, at a CAGR of 11.3% over the forecast years.
Genomics Market
The Genomics Market is About to Change Healthcare sector with significant emergence Digital Genome Market as digitization of life is compelling companies in numerous industries to imagine how biotech could help enhance their top and bottom lines, whether by curbing product development timelines or generating new products that were never before imaginable. The genomics market size is set to reach USD 24.5 billion by 2025, at a CAGR of 11.2% over the forecast years. Where Gene Editing Market size is expected to reach USD 8.56 billion by 2025, growing at a compounded annual growth rate of 13.2% during the forecast period 2017-2025.
Digital pathology Market
wide-ranging applications like health and pharmaceutical sectors, education and contract research organizations, realized benefits of this sophisticated technology have encouraged high growth in digital pathology market, which is estimated to be worth USD 7.1 billion by 2024 at a CAGR of 16% over the forecast period. Regionally, APAC would exhibit the highest CAGR of 25% over the forecast period due to the expansion of the visualization of real digital slide-based routine surgical pathology in practice.
Contact for more Info:
Steve Blade
(Global Sales Head)
USA: + 1-646-568-7747
Canada: +1-437-886-1181
UK: +44-203-318-6627
Comments
Post a Comment